Literature DB >> 7630419

Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide.

A C Avery1, Z S Zhao, A Rodriguez, E K Bikoff, M Soheilian, C S Foster, H Cantor.   

Abstract

Not all peripheral tissue antigens enter the thymus and it is unclear how the immune system remains tolerant to this class of self antigen. As tolerance to self peptides can generate gaps in the T-cell repertoire for cross-reactive foreign antigens, we investigated whether this mechanism might also diminish autoimmune reactions to similar peptides expressed by peripheral tissues. Herpes stromal keratitis (HSK) is a virally induced autoimmune reaction against corneal tissues mediated by T cells, and is a leading cause of human blindness. Resistance to HSK in mice is associated with allotypic variation in immunoglobulin genes, possibly because circulating immunoglobin-derived peptides can cross-tolerize T cells specific for corneal tissue autoantigens. Here we show that HSK is mediated by T-cell clones specific for corneal self antigens which also recognize an allotype-bearing peptide derived from IgG2a, and that exposure of HSK-susceptible mice to a soluble form of this peptide confers resistance to HSK. Shared expression of peptide subsequences between sequestered tissue proteins and circulating proteins may be important for maintenance of self-tolerance and prevention of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630419     DOI: 10.1038/376431a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Genes predisposing to autoimmunity augment constitutive major histocompatibility complex class II-associated presentation of the self-antigen IgG2a in vivo.

Authors:  K Bartnes; X Li; M Iwamoto; S Izui; K Hannestad
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.

Authors:  Andrew J Lepisto; Gregory M Frank; Min Xu; Patrick M Stuart; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.

Authors:  S P Deshpande; S Lee; M Zheng; B Song; D Knipe; J A Kapp; B T Rouse
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR.

Authors:  A Vögtlin; C Fraefel; S Albini; C M Leutenegger; E Schraner; B Spiess; H Lutz; M Ackermann
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers.

Authors:  Kazumi Norose; Akihiko Yano; Xiang-Ming Zhang; Elizabeth Blankenhorn; Ellen Heber-Katz
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 6.  Virus-induced immunopathology.

Authors:  B T Rouse
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

7.  Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells.

Authors:  K Bartnes; K Hannestad
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

8.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas.

Authors:  Min Xu; Andrew J Lepisto; Robert L Hendricks
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

10.  Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice.

Authors:  D J Maggs; E Chang; M P Nasisse; W J Mitchell
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.